| Imfinzi | 🇺🇸United States | 50MG/ML | injectable | Marketed | Astrazeneca UK LTD |
| Imfinzi | 🇺🇸United States | 120MG/2.4ML | Injection | Marketed | AstraZeneca UK Ltd |
| Imfinzi | 🇪🇺European Union | | | Authorised | AstraZeneca AB |
| Imfinzi 50 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 120 mg | concentrado para solución para perfusión | Marketed | Astrazeneca Ab |
| Imfinzi 50 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 500 mg | concentrado para solución para perfusión | Marketed | Astrazeneca Ab |
| Imfinzi 50 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 500 mg | concentrado para solución para perfusión | Marketed | Astrazeneca Ab |
| Imfinzi 50 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 120 mg | concentrado para solución para perfusión | Marketed | Astrazeneca Ab |
| Imfinzi 50 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 120 mg | concentrado para solución para perfusión | Marketed | Astrazeneca Ab |
| Imfinzi 50 MG/ML Concentrado Para Solucion Para Perfusion | 🇪🇸Spain | 500 mg | concentrado para solución para perfusión | Marketed | Astrazeneca Ab |
| Imfinzi | 🇮🇹Italy | | Concentrato per soluzione per infusione | Authorised | Astrazeneca AB |
| Imfinzi 50 mg/ml, concentraat voor oplossing voor infusie | 🇳🇱Netherlands | | Concentraat voor oplossing voor infusie | Authorised | AstraZeneca AB |
| Imfinzi | 🇨🇦Canada | 50 MG / ML | Solution | Marketed | Astrazeneca Canada INC |
| Imfinzi | 🇧🇷Brazil | | | Authorised | Astrazeneca do Brasil Ltda |
| Imfinzi Concentrate for Solution for Infusion 50 MG/ML | 🇸🇬Singapore | 50 mg/ml | infusion, solution concentrate | Authorised | Astrazeneca Singapore Pte LTD |
| Imfinzi® | 🇷🇸Serbia | 50mg/ml | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Imfinzi® | 🇷🇸Serbia | 50mg/ml | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Imfinzi | 🇭🇷Croatia | | | Marketed | |
| Imfinzi | 🇳🇿New Zealand | | Inj 50 mg per ml, 2.4 ml vial | Funded | |
| Imfinzi | 🇳🇿New Zealand | | Inj 50 mg per ml, 10 ml vial | Funded | |
| IMFINZI 120 mg / 2.4 ml | 🇸🇦Saudi Arabia | | | Authorised | AstraZeneca Pharmaceuticals LP |
| IMFINZI 500 mg / 10 ml | 🇸🇦Saudi Arabia | | | Authorised | AstraZeneca Pharmaceuticals LP |
| IMFINZI 50 mg/ml | 🇷🇴Romania | 50mg/ml | conc. pt. sol. perf. | Status unknown | Astrazeneca AB |
